Protective effects of white button mushroom (agaricus bisporus) against hepatic steatosis in ovariectomized mice as a model of postmenopausal women

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Kanaya, Noriko ^a   Kubo, Makoto ^a   Liu, Zheng ^a   Chu, Peiguo ^a   Wang, Charles ^a   Yuan, Yate Ching ^a   Chen, Shiuan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASEIN; CELLULOSE; CHOLINE BITARTRATE; CORN OIL; CYSTEINE; FAS ANTIGEN; FATTY ACID ELONGASE 6; FATTY ACID SYNTHASE; FUNGAL EXTRACT; LARD; LIVER ENZYME; LIVER X RECEPTOR; MALTODEXTRIN; STARCH; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUCROSE; TERT BUTYLHYDROQUINONE; UNCLASSIFIED DRUG; VITAMIN MIXTURE; ACYLTRANSFERASE; FATTY ACID; FATTY ACID ELONGASES; PROTECTIVE AGENT;

AGARICUS BISPORUS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; FATTY ACID SYNTHESIS; FATTY LIVER; FOOD COMPOSITION; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER WEIGHT; MICROARRAY ANALYSIS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; AGARICUS; ANIMAL; BIOSYNTHESIS; DIET THERAPY; FEMALE; GENETICS;

AGARICUS BISPORUS; ANIMALIA; BASIDIOMYCOTA; MUS;

ACETYLTRANSFERASES; AGARICUS; ANIMALS; DOWN-REGULATION; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; FATTY LIVER; FEMALE; HUMANS; MICE; OVARIECTOMY; POSTMENOPAUSE; PROTECTIVE AGENTS;

EID: 80055027583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026654     Document Type: Article

References (32)

1. Postic C, Girard J, (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118: 829-838.
2. Sung KC, Kim SH, (2011) Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab 96: 1093-1097.
3. Suzuki A, Abdelmalek MF, (2009) Nonalcoholic fatty liver disease in women. Womens Health (Lond Engl) 5: 191-203.
4. Rogers NH, Perfield JW 2nd, Strissel KJ, Obin MS, Greenberg AS, (2009) Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 150: 2161-2168.
5. Pasumarthy L, Srour J, (2010) Nonalcoholic steatohepatitis: a review of the literature and updates in management. South Med J 103: 547-550.
6. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME, (2008) The immunobiology of mushrooms. Exp Biol Med (Maywood) 233: 259-276.
7. Sullivan R, Smith JE, Rowan NJ, (2006) Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 49: 159-170.
8. Jeong SC, Jeong YT, Yang BK, Islam R, Koyyalamudi SR, et al. (2010) White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr Res 30: 49-56.
9. Nagao K, Inoue N, Inafuku M, Shirouchi B, Morooka T, et al. (2009) Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice. J Nutr Biochem 21: 418-423.
10. Chen S, Oh SR, Phung S, Hur G, Ye JJ, et al. (2006) Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res 66: 12026-12034.
11. Luk SU, Lee TK, Liu J, Lee DT, Chiu YT, et al. (2011) Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PLoS One 6: e19804.
12. Fukushima M, Ohashi T, Fujiwara Y, Sonoyama K, Nakano M, (2001) Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp Biol Med (Maywood) 226: 758-765.
13. Bobek P, Ozdin L, Kuniak L, (1996) Effect of oyster mushroom (Pleurotus Ostreatus) and its ethanolic extract in diet on absorption and turnover of cholesterol in hypercholesterolemic rat. Nahrung 40: 222-224.
14. Palomares M, Rodriguez J, Phung S, Stanczyk FZ, Lacey SF, et al. (2011) A dose finding clinical trial of mushroom powder in postmenopausal breast cancer survivors for secondary breast cancer prevention. American Society of Clinical Oncology (ASCO) Meeting Abstract ID:1582.
15. Hoegh-Andersen P, Tanko LB, Andersen TL, Lundberg CV, Mo JA, et al. (2004) Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther 6: R169-180.
16. Xu J, Deng X, Demetriou AA, Farkas DL, Hui T, et al. (2008) Factors released from cholestatic rat livers possibly involved in inducing bone marrow hepatic stem cell priming. Stem Cells Dev 17: 143-155.
17. Hossain S, Hashimoto M, Choudhury EK, Alam N, Hussain S, et al. (2003) Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hypercholesterolaemic rats. Clin Exp Pharmacol Physiol 30: 470-475.
18. Cheng HH, Hou WC, Lu ML, (2002) Interactions of lipid metabolism and intestinal physiology with Tremella fuciformis Berk edible mushroom in rats fed a high-cholesterol diet with or without Nebacitin. J Agric Food Chem 50: 7438-7443.
19. Gutierrez-Grobe Y, Ponciano-Rodriguez G, Ramos MH, Uribe M, Mendez-Sanchez N, (2010) Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol 9: 402-409.
20. Nemoto Y, Toda K, Ono M, Fujikawa-Adachi K, Saibara T, et al. (2000) Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest 105: 1819-1825.
21. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, et al. (2004) Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89: 61-70.
22. Jordan VC, (2003) Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2: 205-213.
23. Andersson T, Simonyte K, Andrew R, Strand M, Buren J, et al. (2009) Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal women. PLoS One 4: e8475.
24. Miyazaki M, Dobrzyn A, Man WC, Chu K, Sampath H, et al. (2004) Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and-independent mechanisms. J Biol Chem 279: 25164-25171.
25. Shimamura K, Nagumo A, Miyamoto Y, Kitazawa H, Kanesaka M, et al. (2010) Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6. Eur J Pharmacol 630: 34-41.
26. Gibbons GF, (1994) A comparison of in-vitro models to study hepatic lipid and lipoprotein metabolism. Curr Opin Lipidol 5: 191-199.
27. Grefhorst A, Elzinga BM, Voshol PJ, Plosch T, Kok T, et al. (2002) Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 277: 34182-34190.
28. Kanaya N, Chen S, (2010) Conjugated linoleic acid reduces body weight gain in ovariectomized female C57BL/6J mice. Nutr Res 30: 714-721.
29. Edwards PA, Kennedy MA, Mak PA, (2002) LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol 38: 249-256.
30. Sgarbi DB, da Silva AJ, Carlos IZ, Silva CL, Angluster J, et al. (1997) Isolation of ergosterol peroxide and its reversion to ergosterol in the pathogenic fungus Sporothrix schenckii. Mycopathologia 139: 9-14.
31. Shao S, Hernandez M, Kramer JK, Rinker DL, Tsao R, (2010) Ergosterol profiles, fatty acid composition, and antioxidant activities of button mushrooms as affected by tissue part and developmental stage. J Agric Food Chem 58: 11616-11625.
32. Reagan-Shaw S, Nihal M, Ahmad N, (2008) Dose translation from animal to human studies revisited. Faseb J 22: 659-661.